PB1739: ADVERSE EFFECTS OF ASPARAGINASE IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA

PB1739: ADVERSE EFFECTS OF ASPARAGINASE IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA

Bibliographic Details
Main Authors:	Wafa Chenbah, Nesrine Ben Sayed, Haifa Regaieg, Monia Guermazi, Yosra Ben Youssef, Emna Bouslama, Kmira Zahra, Abderrahim Khelif
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000973816.64500.0e

Similar Items

PB2263: TOXICITY PROFILE OF SALVAGE CHEMOTHERAPY REGIMENS IN PATIENTS WITH RELAPSED/ REFRACTORY HODGKIN LYMPHOMA.
by: Kmira Zahra, et al.
Published: (2023-08-01)

PB2556: MEGALOBLASTIC ANEMIA: EPIDEMIOLOGICAL, CLINICAL, AND ETIOLOGICAL PROFILE: ABOUT 200 CASES.
by: Kmira Zahra, et al.
Published: (2023-08-01)

PB2069: ELTROMBOPAG WITH IMMUNO SUPPRESSIVE THERAPY IN SEVERE ACQUIRED APLASTIC ANEMIA IN CHILDREN AND ADOLESCENTS: A MONOCENTRIC EXPERIENCE
by: Nesrine Ben Sayed, et al.
Published: (2023-08-01)

PB2262: PROGNOSTIC FACTORS IN PATIENTS WITH RELAPSED/REFRACTORY HODGKINN LYMPHOMA
by: Kmira Zahra, et al.
Published: (2023-08-01)

Acquired hemophilia A following COVID-19 vaccine: a case report
by: Bouselama Emna, et al.
Published: (2023-03-01)

Invasive infection caused by Geotrichum capitatum in three patients with acute myeloid leukemia
by: Sana Rouis, et al.
Published: (2020-09-01)

A Case of Acquired Aplastic Anemia after Severe Hepatitis- Probably Induced by the Pfizer/BioNTech Vaccine: A Case Report and Review of Literature
by: Zahra Kmira, et al.
Published: (2023-07-01)

Follow-Up Of Hemophiles And Management Of Complications
by: Monia Zaier, et al.
Published: (2023-01-01)

Primary B cell lymphoma of the tongue base: a case report
by: Achour Bechir, et al.
Published: (2016-11-01)

Multiple myeloma associated with an Evan's syndrome
by: Achour Bechir, et al.
Published: (2016-11-01)

PB2560: LYSOSOMAL STORAGE DISEASES: GUACHER’S DISEASE AND NIEMANPICK ‘S DISEASES: STUDY OF CLINICAL, CYTOLOGICAL AND ENZYMATIC ASPECTS
by: Lina Mohamed, et al.
Published: (2023-08-01)

PB1807: OUTCOME OF CORE BINDING FACTOR ACUTE MYELOID LEUKEMIA IN CHILDREN AND ADOLESCENTS: A SINGLE CENTER EXPERIENCE
by: N. Ben Sayed, et al.
Published: (2022-06-01)

PB2062: EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC FEATURES OF REFRACTORY HODGKIN’S LYMPHOMA.
by: R. Ben Sghaier, et al.
Published: (2022-06-01)

PB1919: MATURE B-CELL NEOPLASMS CD5 NEGATIVE: CONFRONTATION CYTOMETRY-CYTOLOGY
by: Hanen Ben Cheikh, et al.
Published: (2023-08-01)

PB2241: CHARACTERISTICS AND OUTCOME OF WARM AUTOIMMUNE HEMOLYTIC ANEMIA (WAIHA) IN ADULTS: A RETROSPECTIVE ANALYSIS OF 110 TUNISIAN PATIENTS
by: E. Bouslama, et al.
Published: (2022-06-01)

Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
by: Luke Maese, et al.
Published: (2022-06-01)

Our Experiences with Asparaginase Activity Measurements in Children with Lymphoblastic Diseases
by: Judit Müller, et al.
Published: (2023-07-01)

Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia
by: Soulaimane M'harzi, et al.
Published: (2022-01-01)

PEG-asparaginase and native Escherichia coli L-asparaginase in acute lymphoblastic leukemia in children and adolescents: a systematic review
by: Camile Valle Medawar, et al.
Published: (2020-01-01)

PB2320: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONG THE ELDERLY: A TUNISIAN MULTICENTER EXPERIENCE.
by: Kmira Zahra, et al.
Published: (2023-08-01)

PB1735: ONLINE CME PROGRAM IMPROVED CLINICIANS’ ABILITY TO MANAGE PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA WITH ASPARAGINASE-BASED THERAPIES
by: Sarah Elizabeth Bomba, et al.
Published: (2023-08-01)

Corrigendum to Acute pancreatitis following L-asparaginase in acute lymphoblastic leukemia
by: Aziza Elouali, et al.
Published: (2023-01-01)

L-Asparaginase Toxicity in the Treatment of Children and Adolescents with Acute Lymphoblastic Leukemia
by: Madalina-Petronela Schmidt, et al.
Published: (2021-09-01)

LIPID PROFILES IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA ON L-ASPARAGINASE THERAPY
by: Janan G. Hasan
Published: (2010-12-01)

Role of L-asparaginase in acute lymphoblastic leukemia: focus on adult patients
by: Rytting ME
Published: (2012-06-01)

Allergic complications of L-asparaginase therapy in children with acute lymphoblastic leukaemia
by: Konstantinidis Georgios, et al.
Published: (2011-01-01)

PB2340: FIRST LINE THERAPY FOR DIFFUSE LARGE B CELL LYMPHOMA AMONGPATIENTS AGED LESS THAN 60 YEARS: A TUNISIAN MULTICENTER EXPERIENCE.
by: Kmira Zahra, et al.
Published: (2023-08-01)

PB1742: FEASIBILITY AND EFFICACY OF A PEG-ASPARAGINASE-BASED TREATMENT PROTOCOL IN ELDERLY PHILADELPHIA-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
by: Chiara Vernarecci, et al.
Published: (2023-08-01)

PB2286: EVALUATION OF THE THERAPEUTIC RESULTS OF LYMPHOBLASTIC LYMPHOMA TREATED ACCORDING TO THE EORTC 58951 PROTOCOL IN CHILDREN ADOLESCENTS AND YOUNG ADULTS
by: Hana Ben Hammamia, et al.
Published: (2023-08-01)

A study of the adverse drug reactions of L-asparaginase in newly diagnosed children with acute lymphoblastic leukemia
by: Harshada Uchil, et al.
Published: (2017-01-01)

l‑Asparaginase from Solanum lycopersicum as a Nutraceutical for Acute Lymphoblastic Leukemia
by: Sarina P. Khabade, et al.
Published: (2024-01-01)

Update on the Use of l-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia
by: Augusto F. Andrade, et al.
Published: (2014-08-01)

Asparaginase in the Treatment of Acute Lymphoblastic Leukemia in Adults: Current Evidence and Place in Therapy
by: Juluri KR, et al.
Published: (2022-05-01)

Coagulation abnormality as a complication of L-asparaginase therapy in childhood lymphoblastic leukemia
by: Djajadiman Gatot, et al.
Published: (2016-10-01)

Minimal residual disease detection in Tunisian B-acute lymphoblastic leukemia based on immunoglobulin gene rearrangements
by: S. Besbes, et al.

A novel t(3;12)(q21;p13) translocation in a patient with accelerated chronic myeloid leukemia after imatinib and nilotinib therapy
by: Ayda Bennour, et al.
Published: (2013-03-01)

Preclinical evaluation of engineered L-asparaginase variants to improve the treatment of Acute Lymphoblastic Leukemia
by: Soumika Sengupta, et al.
Published: (2024-05-01)

Selection of the Optimal L-asparaginase II Against Acute Lymphoblastic Leukemia: An In Silico Approach
by: Adesh Baral, et al.
Published: (2021-09-01)

Toxicity profile of L-asparaginase in children with acute lymphoblastic leukaemia – Single centre experience
by: Rachel Priyanka Pulla, et al.
Published: (2016-01-01)

The Outcome of Children With Acute Lymphoblastic Leukemia Without Receiving Sufficient Dose of L-Asparaginase
by: Gholamreza Bahoush, et al.
Published: (2020-07-01)